Evidence map›Paper›PMID 27462120›Full record

Trial reportThorax2016

Persistence of circulating endothelial microparticles in COPD despite smoking cessation.

Yael Strulovici-Barel, Michelle R Staudt, Anja Krause, Cynthia Gordon, Ann E Tilley, Ben-Gary Harvey, Robert J Kaner, Charleen Hollmann, Jason G Mezey, Hans Bitter and 7 more

2 registry-linked trialsOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Thorax, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00974064 completednot on this map

The Natural History of Gene Expression in Lung Cells of Non-Smokers, Smokers, and Ex-Smokers in Health and Disease

TypeobservationalSponsorWeill Medical College of Cornell UniversityRan2009 to 2013Enrolled171ConditionsChronic Obstructive Pulmonary Disease (COPD), Smoking, Smoking Cessation, Chronic Bronchitis
NCT01776398 recruitingnot on this map

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

TypeobservationalSponsorWeill Medical College of Cornell UniversityRan2012 to 2028Enrolled2,000ConditionsChronic Obstructive Pulmonary Disease (COPD), Smoking, Smoking Cessation, Idiopathic Pulmonary Fibrosis (IPF)
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Smoking cessation and vascular endothelial function.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Extracellular Vesicle-Encapsulated microRNAs as Novel Biomarkers of Lung Health.American journal of respiratory and critical care medicine · 2023
    Article
  10. Review
  11. Review
  12. Review
  13. Revealing lncRNA Biomarkers Related to Chronic Obstructive Pulmonary Disease Based on Bioinformatics.International journal of chronic obstructive pulmonary disease · 2022
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Yael Strulovici-BarelDepartment of Genetic Medicine, Weill Medical College of Cornell University, New York, New York.
Michelle R StaudtDepartment of Genetic Medicine, Weill Medical College of Cornell University, New York, New York.
Anja KrauseDepartment of Genetic Medicine, Weill Medical College of Cornell University, New York, New York.
Cynthia GordonDepartment of Genetic Medicine, Weill Medical College of Cornell University, New York, New York.
Ann E TilleyDepartment of Genetic Medicine, Weill Medical College of Cornell University, New York, New York.
Ben-Gary HarveyDepartment of Genetic Medicine, Weill Medical College of Cornell University, New York, New York.
Robert J KanerDepartment of Genetic Medicine, Weill Medical College of Cornell University, New York, New York.
Charleen HollmannDepartment of Genetic Medicine, Weill Medical College of Cornell University, New York, New York.
Jason G MezeyDepartment of Genetic Medicine, Weill Medical College of Cornell University, New York, New York.
Hans BitterHoffmann-La Roche, Nutley, New Jersey, USA.
Sreekumar G PillaiHoffmann-La Roche, Nutley, New Jersey, USA.
Holly HiltonHoffmann-La Roche, Nutley, New Jersey, USA.
Gerhard WolffHoffmann-La Roche, Nutley, New Jersey, USA.
Christopher S StevensonHoffmann-La Roche, Nutley, New Jersey, USA.
Sudha VisvanathanHoffmann-La Roche, Nutley, New Jersey, USA.
Jay S FineHoffmann-La Roche, Nutley, New Jersey, USA.
Ronald G CrystalDepartment of Genetic Medicine, Weill Medical College of Cornell University, New York, New York.
Cornell University · USLa Roche College · USBoehringer Ingelheim (United Kingdom) · GBNovartis (China) · CN

Funding

Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
Role of Alveolar Macrophages in the Accelerated Emphysema of HIV-1 PositiveP50HL084936 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CRYSTAL, RONALD G · 2007 to 2011
$14.2M
Overlapping Airway Basal Cell Transcriptome Reprogramming in COPD and Lung CancerR01HL107882 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CRYSTAL, RONALD G · 2011 to 2014
$5.8M
HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary EndotheliumU01HL121828 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CRYSTAL, RONALD G, GROSS, STEVEN S · 2013 to 2017
$3.7M
NCATS NIH HHS UL1 TR000457NHLBI NIH HHS P50 HL084936NHLBI NIH HHS R01 HL107882NHLBI NIH HHS U01 HL121828
6 · The paper itself

Abstract

introductionIncreasing evidence links COPD pathogenesis with pulmonary capillary apoptosis. We previously demonstrated that plasma levels of circulating microparticles released from endothelial cells (EMPs) due to apoptosis are elevated in smokers with normal spirometry but low diffusion capacity, that is, with early evidence of lung destruction. We hypothesised that pulmonary capillary apoptosis persists with the development of COPD and assessed its reversibility in healthy smokers and COPD smokers following smoking cessation.

methodsPulmonary function and high-resolution CT (HRCT) were assessed in 28 non-smokers, 61 healthy smokers and 49 COPD smokers; 17 healthy smokers and 18 COPD smokers quit smoking for 12 months following the baseline visit. Total EMP (CD42b

resultsCompared with non-smokers, healthy smokers and COPD smokers had elevated levels of circulating EMPs due to active pulmonary capillary endothelial apoptosis. Levels remained elevated over 12 months in healthy smokers and COPD smokers who continued smoking, but returned to non-smoker levels in healthy smokers who quit. In contrast, levels remained significantly abnormal in COPD smokers who quit.

conclusionsPulmonary capillary apoptosis is reversible in healthy smokers who quit, but continues to play a role in COPD pathogenesis in smokers who progressed to airflow obstruction despite smoking cessation. TRIAL REGISTRATION NUMBER: NCT00974064; NCT01776398.

Indexed as

AdultApoptosisCapillariesCell-Derived MicroparticlesEndothelial CellsEndothelium, VascularFemaleFollow-Up StudiesHumansLungMaleMiddle AgedPulmonary Disease, Chronic ObstructiveRespiratory Function TestsSmoking CessationTomography, X-Ray ComputedCOPD ÀÜ MechanismsSmoking cessationTobacco and the lung

Identifiers

PMID27462120
PMCPMC5536242
OpenAlexW2488299342

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.